Similar to Gli1 regulation by K-Ras in pancreatic cancer, HRAS or NRAS mutation in melanoma stimulates Gli1 nuclear translocation by antagonizing the suppressive effect of SuFu through MEK1/2. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.